Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2020-02-06 14:14:00
Oslo, 6 February 2020: Ultimovacs ASA ("Ultimovacs", ticker ULTIMO), a pharmaceutical company developing novel immunotherapies against cancer, invites to a presentation of its fourth quarter 2019 results on Friday 14 February 2020. The presentation by the company's management team will take place in meeting room Nyland at Thon Hotel Vika Atrium (Munkedamsveien 45, 0250 Oslo) at 09:00 CET on Friday 14 February 2020. The presentation can be followed as a live webcast (access through link https://channel.royalcast.com/webcast/hegnarmedia/20200214_10/) which will also be available on our website. It will be possible to post questions during the presentation through the webcast. The report and presentation will also be available on the company website from 08:00 CET the same day. For further information, please see www.ultimovacs.com or contact: Øyvind Kongstun Arnesen, CEO oeyvind.arnesen@ultimovacs.com, +47 469 33 810 Hans Vassgård Eid, CFO hans.eid@ultimovacs.com, +47 469 19 822